European Heart Journal· 2022Q1· Guideline
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
- 2,926citations
- Q1SCImago
- 2022year
Short summary
The 2022 ESC Guidelines introduce a new risk stratification tool for sudden cardiac death (SCD) in patients with ventricular arrhythmias (VAs), incorporating genetic testing and advanced imaging.
AI-generated from the title and abstract; the full text is not read.
Key points
- Updated guidelines provide a comprehensive framework for managing ventricular arrhythmias (VAs) and preventing sudden cardiac death (SCD).
- A new risk stratification tool is introduced, incorporating genetic testing and advanced imaging alongside traditional parameters.
- Emphasis is placed on individualized patient management and tailored therapeutic strategies.
- Recommendations cover pharmacological, interventional (ablation), and device-based therapies for VAs and SCD prevention.
AI-generated from the title and abstract; the full text is not read.
Abstract
International audience
The authors' abstract, as published at the source. European Heart Journal, 2022 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Cardiology and Cardiovascular Medicine
Cardiology and Cardiovascular MedicineMedicine